AI
          HIMSS24
          
      
                    
            
  Prashant Natarajan, VP of strategy and products at H20.ai, says he is looking forward to discussing generative AI and the patient experience as well as strategies and success stories with fellow HIMSS24 attendees.
 
        
        
          Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, describes the company's AI-enabled software to detect illicit diversion of controlled and non-controlled substances in patient care and the use of AI in its wider portfolio.
 
        
        
          
          HIMSS24
          
      
                    
            
  Brenna Loufek, SaMD regulatory affairs manager at Mayo Clinic, discusses her HIMSS24 session on bringing AI-enabled digital health tools built under research into the clinical setting and what she hopes the audience will gain from the discussion.
 
        
        
          Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.
        
        
          Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, relays how genAI is impacting various sectors of healthcare and how harnessing the tech will extend human discovery in medicine.
 
        
        
          Jonathon Feit, CEO of Beyond Lucid Technologies, describes how the company utilizes AI to analyze patient information by pulling patient data from various resources to inform and connect EMS providers with healthcare systems.
        
        
          Florida Atlantic University Charles E. Schmidt College of Medicine's Harshal Sanghavi and Dr. Manish Gupta describe the framework used when implementing AI in the healthcare system and utilizing the technology for sports medicine.
 
        
        
          
          HIMSS24
          
      
                    
            
  Dr. Jonathan Chen, assistant professor at Stanford Center for Biomedical Informatics Research, previews his upcoming HIMSS24 session on the difficulty of pinpointing what is real in AI and the need for cautious optimism when using it.
        
        
          Dr. Eve Cunningham, chief of virtual care and digital health at Providence, explains how the health system is implementing AI, vetting companies in the space to ensure security and facing challenges in solidifying provider adoption.
 
        
        
          Harjinder Sandhu, Microsoft CTO of health platforms and solutions, discusses the readiness of OpenAI for use in healthcare, bias within AI and GPT-4, and recommendations for regulators.
 
        
        
           
 
 
 
 
 
 
 
 
